BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15202326)

  • 1. [Osteoporosis associated with inflammatory bowel diseases].
    Miheller P; Tóth M; Pregun I; Tulassay Z
    Orv Hetil; 2004 May; 145(20):1045-51. PubMed ID: 15202326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: Osteoporosis and inflammatory bowel disease.
    Bernstein CN; Leslie WD
    Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease.
    Valentine JF; Sninsky CA
    Am J Gastroenterol; 1999 Apr; 94(4):878-83. PubMed ID: 10201450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.
    Katz S
    Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postmenopausal osteoporosis].
    László A
    Orv Hetil; 2004 Jan; 145(1):3-13. PubMed ID: 15222134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and pharmacologic therapy of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Jul; 144(28):1373-9. PubMed ID: 12914121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of osteoporosis in inflammatory bowel disease.
    Reinshagen M; Von Tirpitz C
    Minerva Med; 2004 Dec; 95(6):481-7. PubMed ID: 15785433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: bone disease in inflammatory bowel disease.
    Schulte CM
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():43-9. PubMed ID: 15352893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
    Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of osteoporosis and osteopenia in children--own experience].
    Chlebna-Sokół D; Błaszczyk A; Rusińska A; Loba-Jakubowska E
    Przegl Lek; 2003; 60(1):5-11. PubMed ID: 12884638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategy for osteoporosis in gastroenterology.
    Scott EM; Scott BB
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):689-96; discussion 696-8. PubMed ID: 9744699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis: strategies for prevention and management.
    Keen R
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):109-22. PubMed ID: 17350547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of bone loss in inflammatory bowel disease.
    Lichtenstein GR
    Semin Gastrointest Dis; 2001 Oct; 12(4):275-83. PubMed ID: 11726081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
    Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
    Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Aug; 144(31):1551-2. PubMed ID: 14502870
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.
    Henderson S; Hoffman N; Prince R
    Am J Gastroenterol; 2006 Jan; 101(1):119-23. PubMed ID: 16405543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of osteoporosis with antiresorptive drugs].
    Vestergaard P; Mosekilde L; Brixen K
    Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.